Search All News
Esophageal Squamous Cell Carcinoma has a strong tendency to metastasize. Unfortunately, ESCC is usually diagnosed at an advanced stage, when it has an overall survival rate of only about 20 percent.
A new three-year, $2.5 million grant from Stand Up to Cancer (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by HICCC director Anil K. Rustgi, MD.
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
- April 15, 2022
Congratulations to Dr. Joel Gabre, recipient of a 2022 Research Scholar Award from the American Gastroenterological Association (AGA) Research Foundation.
- July 28, 2021
Congratulations to Ricardo Cruz-Acuña, PhD, recent recipient of the Charles H. Revson Senior Fellowship in Biomedical Science to support his work in esophageal adenocarcinoma.
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
- April 2, 2021
In a new study, researchers from the HICCC pinpoint a new potential target in lung metastases of esophageal squamous cell carcinoma.